FierceHealthcareFierceHealthITFierceHealthFinanceFierceEMRHospital ImpactFierceMobileHealthcare   FiercePharma

Pharmas cutting sales forces; Ranbaxy accused of distributing weak AIDS drugs;

Tools
Tags
Ranbaxy
Prevnar
Pneumococcus Vaccine
Hiv Drugs
HIV
Generic Drug Maker
Boehringer Ingelheim

> Pharmaceutical companies have been cutting sales forces recently. The most recent is Boehringer Ingelheim, which will halve the ranks of its neurology sales force. FiercePharma

> The ongoing investigation of generic drug maker Ranbaxy now includes a look at charges that it made weak or impure HIV drugs given to thousands of African AIDS patients. FiercePharma

> Researchers are working to develop a low-cost, next-gen pneumococcus vaccine that works against a wider range of pneumococcus bacteria than industry standard Prevnar. FierceVaccines

> According to a new study by healthcare IT company Logicalis, data storage is the top driver behind many hospital IT projects underway right now. FierceHealthIT

And Finally... Nice try, lady. Just drop the rat and put your hands up. Article

Bookmark and Share
Get Your FREE FierceHealthcare Email Newsletter:
Be the first to comment

Comments

Post new comment

The content of this field is kept private and will not be shown publicly.

More information about formatting options

To combat spam, please enter the code in the image.